Clinical trial
Population Pharmacokinetics of Levofloxacin in Intensive Care Patients With Severe Community-acquired Pneumonia.
NCT02018081 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Population Pharmacokinetics of Levofloxacin in Intensive Care Patients With Severe Community-acquired Pneumonia.
- Lead sponsor
- University Hospital, Toulouse
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2012
- Completion date
- September 30, 2014
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
community-acquired pneumonia, intensive care unit syndrome